Understanding Sanofi's Share Structure and Voting Rights
Sanofi, a prominent leader in the pharmaceutical industry, offers detailed insights into its corporate governance through information on the total number of voting rights and shares. This data is crucial for investors and stakeholders interested in understanding the company's financial landscape. A société anonyme based in France, Sanofi holds a registered capital that underscores its strong foundation in the market.
Key Financial Figures as of October 2025
As of a specific date in October 2025, Sanofi reported the following significant figures related to its share capital:
- Total issued shares: 1,227,469,992
- Real voting rights (excluding treasury shares): 1,348,747,993
- Theoretical voting rights (including treasury shares): 1,361,720,228
These numbers demonstrate the scale of Sanofi’s operations and its commitment to transparency in shareholding structure.
Importance of Voting Rights
Voting rights play a pivotal role in corporate governance, allowing shareholders to influence decision-making processes within the company. By understanding these rights, investors can assess their power and ability to affect change within the organization. The distinction between real voting rights and theoretical ones highlights the importance of effective management and strategic shareholding.
Regulatory Compliance and Transparency
Sanofi adheres to strict regulations outlined in the French Commercial Code, which mandates disclosure of voting rights related information to ensure fair practices in the financial market. This commitment to compliance provides investors with the assurance that the company operates within the legal frameworks established by financial authorities.
How Investors Can Access This Information
The information regarding shares and voting rights is readily available on Sanofi’s official website under the "Regulated Information in France" section. Investors can easily navigate to find detailed reports and updates related to their investments.
The Significance of Sanofi's Corporate Governance
Sanofi’s proactive approach to sharing information about its corporate governance reflects its dedication to maintaining investor trust and confidence. This transparency is essential in fostering a positive relationship between the company and its shareholders. Investors looking closely at Sanofi can thus benefit from understanding how their interests align with the company's strategic goals.
Contacting the Investor Relations Department
For those seeking further details or clarification, Sanofi provides access to its Investor Relations Department. Interested parties can reach out via email at investor.relations@sanofi.com to inquire more about share structures, governance policies, and other relevant information.
Frequently Asked Questions
What is the total number of issued shares for Sanofi?
As of October 2025, Sanofi has issued a total of 1,227,469,992 shares.
How many real voting rights are available to shareholders?
Sanofi has a total of 1,348,747,993 real voting rights excluding treasury shares.
How do treasury shares affect voting rights?
Treasury shares do not grant voting rights, which is why real voting rights figures exclude them.
Where can I find more information on Sanofi's shares?
Investors can find detailed information about Sanofi's shares on the company’s official website under the regulated information section.
How can I contact Sanofi for investor inquiries?
Investors can contact Sanofi's Investor Relations Department via email at investor.relations@sanofi.com.